Navigation Links
UT Southwestern testing new hybrid hearing device combining advantages of hearing aids, implants
Date:4/17/2008

DALLAS April 17, 2008 A new hybrid hearing aid/cochlear implant device designed for patients who can benefit from both is being evaluated by UT Southwestern Medical Center otolaryngologists, as part of a multisite, national study.

The cross-breed device, called the DUET Electric-Acoustic System, or EAS, is already used in Europe, but not yet approved for use in the U.S. It targets a population currently falling through the cracks borderline cases for which hearing aids dont adequately distinguish sounds, but for who some natural hearing remains. For these individuals, cochlear implants that entirely replace natural hearing arent recommended either.

Hearing aids are typically worn on the outside of the ear by people who still have some natural hearing. Cochlear implants are surgically implanted into the ear and pick up lost middle- and higher-frequency sounds. They replace lost natural hearing by digitizing electrical impulses sent to the brain via wires implanted in the ear. The brain then interprets that as sound.

Most people with hearing difficulties have one or the other device, but not both.

Initial studies on the hybrid device suggest there is a synergistic effect achieved by maintaining the natural hearing and coupling it with the cochlear implant, particularly for distinguishing speech in noisy environments. The device both amplifies low frequencies and electronically stimulates middle and high frequencies.

The implant is specifically designed with a thin electrode to occupy less space in the inner ear. It is implanted by special surgical techniques to preserve natural hearing.

What patients can hope to get from the investigational device is a significant improvement in the ability to understand speech, especially in a noisy situation, said Dr. Peter Roland, chairman of otolaryngology-head and neck surgery at UT Southwestern.

The device is made by MED-EL Corp., which conducts the initial patient screening for the trial. The device is still investigational, so all of the potential risks are not known, Dr. Roland said. The most common serious complication is loss of what hearing is left in the ear that receives the implant. The opposite ear is unaffected. Significant hearing loss has occurred in 10 percent to 15 percent of recipients to date.

UT Southwestern is among about a dozen sites participating in the national trial. UT Southwestern researchers are seeking about a dozen participants, said Dr. Roland.

Potential study participants must be at least 18 years old, have moderate sloping to severe profound hearing loss, and have had minimal results from traditional hearing aids. Patients appropriate for the study will still have some natural hearing left but find themselves struggling to understand loud speech, particularly in noisy, crowded situations, even while wearing high-quality hearing aids. The target patient has hearing loss in high frequencies, but also requires a hearing aid to boost low-frequency sound.

We need people who are not getting enough benefit from their hearing aids to live normal lives, but who are not quite deaf enough for a regular cochlear implant, explained Dr. Roland.


'/>"/>

Contact: Russell Rian
russell.rian@utsouthwestern.edu
214-648-3404
UT Southwestern Medical Center
Source:Eurekalert  

Related medicine news :

1. UT Southwestern researchers investigate predictors for sickle-cell-anemia complications
2. UT Southwestern surgeons complete North Texas first single-incision gallbladder removal
3. UT Southwestern plastic surgeons deploy new carbon dioxide-based fractional laser
4. BMI criteria for obesity surgery should be lowered, UT Southwestern researchers suggest
5. UT Southwestern: Patients with mild Cushing syndrome may benefit from adrenalectomy
6. Physicians seek to improve the quality of sleep in ICU, researchers at UT Southwestern report
7. UT Southwestern urologist uses Botox to treat debilitating condition
8. UT Southwestern researcher named Howard Hughes Medical Institute investigator
9. 2 UT Southwestern researchers elected to National Academy of Sciences Institute of Medicine
10. UT Southwestern investigating hypothermic technique in treating pediatric head injuries
11. UT Southwestern scientist receives NIH Directors New Innovator Award
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UT Southwestern testing new hybrid hearing device combining advantages of hearing aids, implants
(Date:4/24/2017)... ... April 24, 2017 , ... According to the ... now claim the lives of 62 Americans each day.(1) Yet since 2011, the ... distributors, pharmacies and prescribers by more than half.(2) Novus Medical Detox Center ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... of individuals with HIV because it is not known to have significant interactions ... favorable effects to both lower cholesterol levels and dampen inflammation in the bloodstream. ...
(Date:4/24/2017)... ... April 24, 2017 , ... Donna Parker, L. Ac. reads all sorts ... any of them to be very practical. She wanted to write a guide/workbook that ... in their health. It prompted her in writing “ A Clear Path to a ...
(Date:4/24/2017)... ... April 24, 2017 , ... “The Saint with Trin, and Omega ... Omega Station” is the creation of published author, Chris Jackson. Chris Jackson grew ... works in the Dallas Independent School District teaching English. He is heavily involved in ...
(Date:4/24/2017)... BARCELONA, Spain (PRWEB) , ... April 24, 2017 ... ... focused on the development of next generation neuro-thrombectomy systems for the treatment of ... test and manufacture its ANCD BRAIN device as the product advances towards regulatory ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 2017 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), ... Healthcare Investor Conference 2017 at the Sheraton Hotel in ... Executive Officer of the Company is scheduled to present on Tuesday, ... and the Chairman of the Board, Tony Holler ... ...
(Date:4/19/2017)... Calif. , April 19, 2017  IRIDEX Corporation ... will release financial results for the first quarter 2017 ... 2017.  The Company,s management team will host a corresponding ... p.m. ET. Investors interested in listening to ... 707-0665 for domestic callers or (703) 326-3030 for international ...
(Date:4/19/2017)... NASHVILLE , Tenn. and DALLAS , ... and EndoStim, Inc., announced that the first patients in ... with the EndoStim device in the Lower Esophageal Sphincter ... is a minimally-invasive implantable device designed to provide long-term ... through neurostimulation. GERD affects nearly 65 million ...
Breaking Medicine Technology: